The best indicator for DocuSign
We backtested 382 indicators across daily, weekly and hourly charts on real DocuSign history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
SMC: Change of Character
On the daily chart, this is the strongest risk-adjusted edge we found for DocuSign over ~8.1 years — beating buy-and-hold by 18.5% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Volume Oscillator | Weekly | 18.5% | 0.78 | -31.2% | 70.6% | 17 | 17.6% |
| 2 | SMC: Change of Character ✓ | Daily | 19.3% | 0.65 | -40.7% | 65.0% | 20 | 18.5% |
| 3 | Ehlers Decycler | Weekly | 17.9% | 0.64 | -46.0% | 50.0% | 22 | 17.1% |
| 4 | Predictive Ranges ✓ | Weekly | 29.0% | 0.89 | -49.0% | 60.0% | 10 | 28.2% |
| 5 | ADX Strong Trend ✓ | Daily | 11.4% | 0.59 | -34.2% | 53.3% | 30 | 10.6% |
| 6 | Pascal's Weighted MA ✓ | Weekly | 13.7% | 0.59 | -49.8% | 56.2% | 16 | 12.8% |
| 7 | On-Balance Volume | Weekly | 15.6% | 0.57 | -53.8% | 44.4% | 27 | 14.7% |
| 8 | Predictive Ranges ✓ | Daily | 14.0% | 0.56 | -46.9% | 43.1% | 58 | 13.2% |
| 9 | Relative Volatility Index ✓ | Weekly | 14.6% | 0.56 | -54.4% | 31.6% | 19 | 13.8% |
| 10 | Chaikin Money Flow | Daily | 14.5% | 0.55 | -58.4% | 39.3% | 107 | 13.7% |
| 11 | Chaikin Volatility ✓ | Weekly | 11.5% | 0.55 | -39.3% | 57.9% | 19 | 10.7% |
| 12 | RSI (9) | Weekly | 13.6% | 0.54 | -50.2% | 41.7% | 24 | 12.8% |
| 13 | Price Volume Trend ✓ | Weekly | 17.3% | 0.62 | -40.6% | 30.8% | 13 | 16.5% |
| 14 | Momentum (50) ✓ | Daily | 13.4% | 0.53 | -43.1% | 43.4% | 53 | 12.6% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For DocuSign, SMC: Change of Character on the daily timeframe gave the best balance of return and risk in our test. It beat buy-and-hold — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.